Enzon Pharmaceuticals Inc (ENZN)
0.0780
+0.01
(+7.75%)
USD |
OTCM |
Apr 23, 11:07
Enzon Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | -810.3% |
| September 30, 2021 | |
| June 30, 2021 | -6.53% |
| March 31, 2021 | 2.89% |
| December 31, 2020 | -1.25K% |
| September 30, 2020 | -5.09K% |
| June 30, 2020 | -2.95K% |
| March 31, 2020 | -12.10K% |
| December 31, 2019 | -534.7% |
| September 30, 2019 | -16.25K% |
| June 30, 2019 | -10.14% |
| March 31, 2019 | |
| December 31, 2018 | 96.62% |
| September 30, 2018 | |
| June 30, 2018 | -337.7% |
| March 31, 2018 | -2.08K% |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 61.77% |
| March 31, 2017 | 44.79% |
| December 31, 2016 | -540.9% |
| September 30, 2016 | 47.13% |
| June 30, 2016 | 45.55% |
| March 31, 2016 | 46.45% |
| December 31, 2015 |
| Date | Value |
|---|---|
| September 30, 2015 | -47.25% |
| June 30, 2015 | 72.84% |
| March 31, 2015 | |
| December 31, 2014 | 92.53% |
| September 30, 2014 | 92.99% |
| June 30, 2014 | 88.62% |
| March 31, 2014 | 94.94% |
| December 31, 2013 | 73.78% |
| September 30, 2013 | 63.00% |
| June 30, 2013 | 58.58% |
| March 31, 2013 | 23.47% |
| December 31, 2012 | -48.45% |
| September 30, 2012 | 37.54% |
| June 30, 2012 | -7.13% |
| March 31, 2012 | -10.10% |
| December 31, 2011 | -50.15% |
| September 30, 2011 | -87.21% |
| June 30, 2011 | -73.63% |
| March 31, 2011 | 2.39% |
| December 31, 2010 | -67.31% |
| September 30, 2010 | -63.14% |
| June 30, 2010 | -40.99% |
| March 31, 2010 | |
| December 31, 2009 | -4.63% |
| September 30, 2009 | 1.03% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.25K%
Minimum
Sep 2019
2.89%
Maximum
Mar 2021
-3.90K%
Average
-1.03K%
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Electromed Inc | 12.23% |
| Armata Pharmaceuticals Inc | -- |